JPS57131725A - Remedy for immune complex disease - Google Patents
Remedy for immune complex diseaseInfo
- Publication number
- JPS57131725A JPS57131725A JP56018429A JP1842981A JPS57131725A JP S57131725 A JPS57131725 A JP S57131725A JP 56018429 A JP56018429 A JP 56018429A JP 1842981 A JP1842981 A JP 1842981A JP S57131725 A JPS57131725 A JP S57131725A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- remedy
- human urine
- acid protease
- buffer solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000024781 Immune Complex disease Diseases 0.000 title abstract 2
- 208000024326 hypersensitivity reaction type III disease Diseases 0.000 title 1
- 208000025883 type III hypersensitivity disease Diseases 0.000 title 1
- 108091005508 Acid proteases Proteins 0.000 abstract 3
- 210000002700 urine Anatomy 0.000 abstract 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 abstract 1
- 208000005777 Lupus Nephritis Diseases 0.000 abstract 1
- 239000006096 absorbing agent Substances 0.000 abstract 1
- 239000008351 acetate buffer Substances 0.000 abstract 1
- 239000007853 buffer solution Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000005227 gel permeation chromatography Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000002504 physiological saline solution Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000006215 rectal suppository Substances 0.000 abstract 1
- 229940100618 rectal suppository Drugs 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56018429A JPS57131725A (en) | 1981-02-10 | 1981-02-10 | Remedy for immune complex disease |
CA000395742A CA1181005A (en) | 1981-02-10 | 1982-02-08 | Therapeutic agent for treatment of allergic diseases, immune complex diseases and tumors |
CH782/82A CH653557A5 (de) | 1981-02-10 | 1982-02-09 | Zur behandlung von allergischen zustaenden, immunkomplexkrankheiten und tumoren geeignetes therapeutisches mittel. |
AU80290/82A AU531314B2 (en) | 1981-02-10 | 1982-02-09 | Therapeutic agent containing human urinary acid protease |
SE8200748A SE455163B (sv) | 1981-02-10 | 1982-02-09 | Uropepsin for anvendning som terapeutikum mot allergiska sjukdomar, immunkomplexsjukdomar och tumorer |
GB8203682A GB2095993B (en) | 1981-02-10 | 1982-02-09 | Compositions containing human urinary acid protease |
IT47761/82A IT1154280B (it) | 1981-02-10 | 1982-02-10 | Agente terapeutico a base di protea si acida e suo impiego in pazienti affetti da disordini allergici,malattie da immuno-complessi e tumori |
DE19823204631 DE3204631A1 (de) | 1981-02-10 | 1982-02-10 | Therapeutisches mittel und dessen verwendung |
FR8202145A FR2499409A1 (fr) | 1981-02-10 | 1982-02-10 | Agent therapeutique a base d'une protease acide, pour le traitement des troubles allergiques, des maladies avec immunocomplexe et des tumeurs |
NL8200509A NL8200509A (nl) | 1981-02-10 | 1982-02-10 | Geneesmiddel voor allergiekwalen, immuuncomplexziekten en tumoren; werkwijze voor het behandelen van patienten die hieraan lijden. |
EP82100973A EP0059346B1 (en) | 1981-02-10 | 1982-02-10 | Therapeutic agent containing a human urinary pepsin |
DE8282100973T DE3273953D1 (en) | 1981-02-10 | 1982-02-10 | Therapeutic agent containing a human urinary pepsin |
US06/365,465 US4540569A (en) | 1981-02-10 | 1982-04-05 | Method for treatment of allergic disorders and immune complex diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56018429A JPS57131725A (en) | 1981-02-10 | 1981-02-10 | Remedy for immune complex disease |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS57131725A true JPS57131725A (en) | 1982-08-14 |
JPS6237611B2 JPS6237611B2 (enrdf_load_stackoverflow) | 1987-08-13 |
Family
ID=11971396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56018429A Granted JPS57131725A (en) | 1981-02-10 | 1981-02-10 | Remedy for immune complex disease |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57131725A (enrdf_load_stackoverflow) |
-
1981
- 1981-02-10 JP JP56018429A patent/JPS57131725A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS6237611B2 (enrdf_load_stackoverflow) | 1987-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Brade et al. | Ifosfamide-pharmacology, safety and therapeutic potential | |
GR76810B (enrdf_load_stackoverflow) | ||
EG19642A (en) | A process for the preparation of oral composition for the treatment of inflammatory bowel diseases | |
JPS5756427A (en) | Medicine containing 2-phenyl-1,2-benzisoselenazole- 3(2h)-one | |
DK452289D0 (da) | Praeparat eller system til behandling af diabetes | |
Gray et al. | Protective effect of pitressin and epinephrine against total body X-irradiation | |
DE3279946D1 (en) | Rectally administrable suppository comprising a drug and an adjuvant | |
ES8504459A1 (es) | Procedimiento para preparar factor de transferencia especifico a un virus determinado. | |
JPS57131725A (en) | Remedy for immune complex disease | |
JPS56138111A (en) | Suppository containing unsaturated fatty acid or salt thereof | |
GB2092001B (en) | Pharmaceutical preparations comprising sodium fructose-1,6-diphosposphate for treatment of burn patients | |
BG96324A (bg) | Фармакологично активно вещество врс, метод за неговото получаване и терапевтичното му приложение | |
Hamaoka et al. | Antibody production in mice: II. The mechanism of antigenic stimulation in the secondary immune response | |
JPS56138110A (en) | Suppository containing citric acid or salt thereof | |
IE44814L (en) | Treatment of gastroenteritis. | |
JPS5793913A (en) | Enhancing agent for spermous vital power | |
JPS56138112A (en) | Suppository containing ascorbic acid or sodium ascorbate | |
JPS55113721A (en) | Immunity regulator | |
DE3568944D1 (en) | Pharmaceutical composition for oral administration containing, on the one hand, as active principle the 9-alpha,11-beta dichloro-16-alpha methyl 21-oxycarbonyldicyclohexylmethyloxy pregna-1,4-diene 3,20-dione and, on the other hand, an inert pharmaceutical excipient which is able to permit the activity of the product in the rectum or in the colon and the utilization of the active principle in the preparation of such a pharmaceutical composition | |
JPS5543041A (en) | Immunity raising agent | |
JPS56138115A (en) | Suppository containing acidic amino acid or derivative thereof | |
JPS5522641A (en) | Antiallergic agent | |
Drozdovskiĭ et al. | Radiosynoviorthese in the treatment of patients with rheumatoid arthritis | |
JPS5629525A (en) | Preventive and remedy for infectious disease in intestine | |
Rojas et al. | Treatment of chronic amebiasis in pediatric patients with a suspension of quinfamide |